nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—prostate cancer	0.591	1	CbGaD
Lubiprostone—CBR1—Doxorubicin—prostate cancer	0.189	1	CbGbCtD
Lubiprostone—CLCN2—prostate gland—prostate cancer	0.00814	0.195	CbGeAlD
Lubiprostone—CLCN2—seminal vesicle—prostate cancer	0.00688	0.165	CbGeAlD
Lubiprostone—CLCN2—epithelium—prostate cancer	0.00598	0.143	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—prostate cancer	0.00493	0.0959	CbGpPWpGaD
Lubiprostone—CLCN2—testis—prostate cancer	0.00358	0.0858	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—prostate cancer	0.00342	0.0665	CbGpPWpGaD
Lubiprostone—CBR1—prostate gland—prostate cancer	0.00326	0.0781	CbGeAlD
Lubiprostone—CBR1—seminal vesicle—prostate cancer	0.00276	0.0661	CbGeAlD
Lubiprostone—CLCN2—lymph node—prostate cancer	0.0026	0.0622	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—prostate cancer	0.00254	0.0494	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—prostate cancer	0.00237	0.0461	CbGpPWpGaD
Lubiprostone—CBR1—renal system—prostate cancer	0.00222	0.0532	CbGeAlD
Lubiprostone—CBR1—urethra—prostate cancer	0.00218	0.0523	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—HPGD—prostate cancer	0.00178	0.0346	CbGpPWpGaD
Lubiprostone—CBR1—bone marrow—prostate cancer	0.00168	0.0402	CbGeAlD
Lubiprostone—CBR1—testis—prostate cancer	0.00144	0.0344	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—TBXAS1—prostate cancer	0.00123	0.024	CbGpPWpGaD
Lubiprostone—CBR1—lymph node—prostate cancer	0.00104	0.0249	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—GSTM3—prostate cancer	0.000937	0.0182	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—HPGDS—prostate cancer	0.000917	0.0178	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP2C19—prostate cancer	0.000911	0.0177	CbGpPWpGaD
Lubiprostone—Dinoprostone—HPGDS—prostate cancer	0.00091	0.578	CrCbGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—prostate cancer	0.000884	0.0172	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—AKR1C3—prostate cancer	0.000855	0.0166	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC39A1—prostate cancer	0.000848	0.0165	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000802	0.0156	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP1B1—prostate cancer	0.000709	0.0138	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GGT1—prostate cancer	0.000686	0.0134	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000634	0.0123	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA3—prostate cancer	0.000573	0.0111	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP1A1—prostate cancer	0.000537	0.0104	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA4—prostate cancer	0.000524	0.0102	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000517	0.0101	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA2—prostate cancer	0.00051	0.00993	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000504	0.0098	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000504	0.0098	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA1—prostate cancer	0.000492	0.00958	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HSP90AB1—prostate cancer	0.000476	0.00927	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—NFE2L2—prostate cancer	0.000434	0.00844	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GPX3—prostate cancer	0.000414	0.00805	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFA—prostate cancer	0.000414	0.00805	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000408	0.00795	CbGpPWpGaD
Lubiprostone—Dinoprostone—SLC22A1—prostate cancer	0.00038	0.242	CrCbGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000377	0.00733	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—CYP2A6—prostate cancer	0.000373	0.00726	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000361	0.00703	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000333	0.00648	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC5A5—prostate cancer	0.000325	0.00632	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—prostate cancer	0.000319	0.00621	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000317	0.00616	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.000316	0.00614	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—NQO1—prostate cancer	0.000314	0.0061	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HSPA1A—prostate cancer	0.000311	0.00606	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.000299	0.00582	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.000299	0.00582	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.000299	0.00582	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—EGR1—prostate cancer	0.000291	0.00567	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GGT1—prostate cancer	0.000291	0.00567	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000285	0.00555	CbGpPWpGaD
Lubiprostone—Dinoprostone—CYP19A1—prostate cancer	0.000283	0.18	CrCbGaD
Lubiprostone—CBR1—NRF2 pathway—RXRA—prostate cancer	0.000273	0.00531	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00027	0.00525	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTP1—prostate cancer	0.000262	0.00509	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFBR2—prostate cancer	0.000262	0.00509	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000255	0.00495	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.000254	0.00495	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000243	0.00473	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—prostate cancer	0.00024	0.00468	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000239	0.00465	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000233	0.00453	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.000227	0.00441	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.000216	0.00421	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.000216	0.00421	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000215	0.00417	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000204	0.00397	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HAO1—prostate cancer	0.000197	0.00384	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.000184	0.00358	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	0.000176	0.00343	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	0.00017	0.0033	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	0.000164	0.00319	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ADI1—prostate cancer	0.000161	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CSAD—prostate cancer	0.000161	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PSAT1—prostate cancer	0.000161	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GRHL1—prostate cancer	0.000161	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TST—prostate cancer	0.000161	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.000157	0.00306	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000156	0.00303	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.000154	0.003	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UGT2B17—prostate cancer	0.00015	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UGT2B15—prostate cancer	0.00015	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GRHPR—prostate cancer	0.00015	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKMT2—prostate cancer	0.00015	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.000146	0.00284	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.000144	0.0028	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM3—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PGAM2—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NAGLU—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AOX1—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—RFK—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT2B1—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MBTPS1—prostate cancer	0.000141	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000137	0.00267	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SRD5A2—prostate cancer	0.000133	0.00259	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NAT1—prostate cancer	0.000133	0.00259	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP3A43—prostate cancer	0.000133	0.00259	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AMACR—prostate cancer	0.000133	0.00259	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DEGS1—prostate cancer	0.000133	0.00259	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000131	0.00255	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.00013	0.00253	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD17B1—prostate cancer	0.000127	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000127	0.00247	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000124	0.00241	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000122	0.00238	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000122	0.00237	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.00012	0.00234	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000115	0.00223	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—B4GALT4—prostate cancer	0.000113	0.0022	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HPGD—prostate cancer	0.000113	0.0022	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TNFRSF21—prostate cancer	0.000107	0.00207	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTAP—prostate cancer	0.000104	0.00202	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP7B1—prostate cancer	0.000104	0.00202	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000101	0.00197	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SRD5A1—prostate cancer	0.000101	0.00196	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT1E1—prostate cancer	0.000101	0.00196	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.81e-05	0.00191	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB1—prostate cancer	9.8e-05	0.00191	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.66e-05	0.00188	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACSL4—prostate cancer	9.64e-05	0.00187	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD17B3—prostate cancer	9.64e-05	0.00187	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.52e-05	0.00185	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ARG2—prostate cancer	9.24e-05	0.0018	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UMPS—prostate cancer	9.24e-05	0.0018	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PHGDH—prostate cancer	9.24e-05	0.0018	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.19e-05	0.00179	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LDHB—prostate cancer	9.06e-05	0.00176	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP3A5—prostate cancer	8.89e-05	0.00173	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TCN2—prostate cancer	8.59e-05	0.00167	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UCP3—prostate cancer	8.59e-05	0.00167	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA3—prostate cancer	8.59e-05	0.00167	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PDHA1—prostate cancer	8.59e-05	0.00167	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC22A3—prostate cancer	8.19e-05	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD3B1—prostate cancer	8.19e-05	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.95e-05	0.00155	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA4—prostate cancer	7.85e-05	0.00153	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TBXAS1—prostate cancer	7.85e-05	0.00153	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.68e-05	0.00149	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA2—prostate cancer	7.65e-05	0.00149	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCG5—prostate cancer	7.56e-05	0.00147	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT1A1—prostate cancer	7.56e-05	0.00147	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA1—prostate cancer	7.38e-05	0.00144	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NAT2—prostate cancer	7.3e-05	0.00142	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTO1—prostate cancer	7.3e-05	0.00142	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD3B2—prostate cancer	7.3e-05	0.00142	CbGpPWpGaD
Lubiprostone—Muscle spasms—Capecitabine—prostate cancer	7.11e-05	0.000572	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.02e-05	0.00137	CbGpPWpGaD
Lubiprostone—Gastritis—Doxorubicin—prostate cancer	7.01e-05	0.000563	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLCB2—prostate cancer	7e-05	0.00136	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LRP2—prostate cancer	7e-05	0.00136	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP2C18—prostate cancer	7e-05	0.00136	CbGpPWpGaD
Lubiprostone—Alanine aminotransferase increased—Doxorubicin—prostate cancer	6.99e-05	0.000561	CcSEcCtD
Lubiprostone—Asthenia—Estradiol—prostate cancer	6.95e-05	0.000558	CcSEcCtD
Lubiprostone—Tremor—Capecitabine—prostate cancer	6.93e-05	0.000557	CcSEcCtD
Lubiprostone—Abdominal distension—Doxorubicin—prostate cancer	6.89e-05	0.000554	CcSEcCtD
Lubiprostone—Ill-defined disorder—Capecitabine—prostate cancer	6.87e-05	0.000552	CcSEcCtD
Lubiprostone—CBR1—Metabolism—P4HB—prostate cancer	6.87e-05	0.00134	CbGpPWpGaD
Lubiprostone—Syncope—Docetaxel—prostate cancer	6.85e-05	0.000551	CcSEcCtD
Lubiprostone—Influenza—Doxorubicin—prostate cancer	6.85e-05	0.00055	CcSEcCtD
Lubiprostone—Pollakiuria—Epirubicin—prostate cancer	6.83e-05	0.000549	CcSEcCtD
Lubiprostone—Palpitations—Docetaxel—prostate cancer	6.75e-05	0.000543	CcSEcCtD
Lubiprostone—Weight increased—Epirubicin—prostate cancer	6.73e-05	0.000541	CcSEcCtD
Lubiprostone—Loss of consciousness—Docetaxel—prostate cancer	6.72e-05	0.00054	CcSEcCtD
Lubiprostone—Dyspnoea—Etoposide—prostate cancer	6.69e-05	0.000538	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC22A1—prostate cancer	6.68e-05	0.0013	CbGpPWpGaD
Lubiprostone—Malaise—Capecitabine—prostate cancer	6.67e-05	0.000536	CcSEcCtD
Lubiprostone—Cough—Docetaxel—prostate cancer	6.67e-05	0.000536	CcSEcCtD
Lubiprostone—Hypersensitivity—Mitoxantrone—prostate cancer	6.65e-05	0.000534	CcSEcCtD
Lubiprostone—Syncope—Capecitabine—prostate cancer	6.64e-05	0.000533	CcSEcCtD
Lubiprostone—Mental disorder—Prednisone—prostate cancer	6.63e-05	0.000533	CcSEcCtD
Lubiprostone—Diarrhoea—Estradiol—prostate cancer	6.63e-05	0.000532	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.6e-05	0.00128	CbGpPWpGaD
Lubiprostone—Erythema—Prednisone—prostate cancer	6.59e-05	0.00053	CcSEcCtD
Lubiprostone—Malnutrition—Prednisone—prostate cancer	6.59e-05	0.00053	CcSEcCtD
Lubiprostone—Palpitations—Capecitabine—prostate cancer	6.54e-05	0.000525	CcSEcCtD
Lubiprostone—Decreased appetite—Etoposide—prostate cancer	6.52e-05	0.000524	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SULT2A1—prostate cancer	6.51e-05	0.00127	CbGpPWpGaD
Lubiprostone—Chest pain—Docetaxel—prostate cancer	6.51e-05	0.000523	CcSEcCtD
Lubiprostone—Myalgia—Docetaxel—prostate cancer	6.51e-05	0.000523	CcSEcCtD
Lubiprostone—Loss of consciousness—Capecitabine—prostate cancer	6.5e-05	0.000522	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Etoposide—prostate cancer	6.48e-05	0.000521	CcSEcCtD
Lubiprostone—Asthenia—Mitoxantrone—prostate cancer	6.47e-05	0.00052	CcSEcCtD
Lubiprostone—Fatigue—Etoposide—prostate cancer	6.47e-05	0.00052	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	6.46e-05	0.000519	CcSEcCtD
Lubiprostone—Cough—Capecitabine—prostate cancer	6.46e-05	0.000519	CcSEcCtD
Lubiprostone—Pain—Etoposide—prostate cancer	6.42e-05	0.000516	CcSEcCtD
Lubiprostone—Constipation—Etoposide—prostate cancer	6.42e-05	0.000516	CcSEcCtD
Lubiprostone—Urinary tract infection—Epirubicin—prostate cancer	6.41e-05	0.000515	CcSEcCtD
Lubiprostone—Dizziness—Estradiol—prostate cancer	6.4e-05	0.000514	CcSEcCtD
Lubiprostone—CBR1—Metabolism—MED12—prostate cancer	6.4e-05	0.00125	CbGpPWpGaD
Lubiprostone—Dry mouth—Docetaxel—prostate cancer	6.36e-05	0.000511	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GNG5—prostate cancer	6.35e-05	0.00124	CbGpPWpGaD
Lubiprostone—Pollakiuria—Doxorubicin—prostate cancer	6.32e-05	0.000508	CcSEcCtD
Lubiprostone—Myalgia—Capecitabine—prostate cancer	6.3e-05	0.000506	CcSEcCtD
Lubiprostone—Chest pain—Capecitabine—prostate cancer	6.3e-05	0.000506	CcSEcCtD
Lubiprostone—Anxiety—Capecitabine—prostate cancer	6.28e-05	0.000504	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	6.26e-05	0.000503	CcSEcCtD
Lubiprostone—Oedema—Docetaxel—prostate cancer	6.24e-05	0.000501	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—prostate cancer	6.23e-05	0.000501	CcSEcCtD
Lubiprostone—Discomfort—Capecitabine—prostate cancer	6.22e-05	0.0005	CcSEcCtD
Lubiprostone—Feeling abnormal—Etoposide—prostate cancer	6.19e-05	0.000497	CcSEcCtD
Lubiprostone—Diarrhoea—Mitoxantrone—prostate cancer	6.17e-05	0.000496	CcSEcCtD
Lubiprostone—Dry mouth—Capecitabine—prostate cancer	6.16e-05	0.000495	CcSEcCtD
Lubiprostone—Vomiting—Estradiol—prostate cancer	6.16e-05	0.000495	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Etoposide—prostate cancer	6.14e-05	0.000493	CcSEcCtD
Lubiprostone—Shock—Docetaxel—prostate cancer	6.14e-05	0.000493	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NCOA3—prostate cancer	6.12e-05	0.00119	CbGpPWpGaD
Lubiprostone—Nervous system disorder—Docetaxel—prostate cancer	6.12e-05	0.000491	CcSEcCtD
Lubiprostone—Ill-defined disorder—Prednisone—prostate cancer	6.12e-05	0.000491	CcSEcCtD
Lubiprostone—Rash—Estradiol—prostate cancer	6.11e-05	0.000491	CcSEcCtD
Lubiprostone—Dermatitis—Estradiol—prostate cancer	6.1e-05	0.00049	CcSEcCtD
Lubiprostone—Tachycardia—Docetaxel—prostate cancer	6.09e-05	0.000489	CcSEcCtD
Lubiprostone—Headache—Estradiol—prostate cancer	6.07e-05	0.000487	CcSEcCtD
Lubiprostone—Skin disorder—Docetaxel—prostate cancer	6.06e-05	0.000487	CcSEcCtD
Lubiprostone—Oedema—Capecitabine—prostate cancer	6.04e-05	0.000485	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.01e-05	0.00117	CbGpPWpGaD
Lubiprostone—Anorexia—Docetaxel—prostate cancer	5.95e-05	0.000478	CcSEcCtD
Lubiprostone—Malaise—Prednisone—prostate cancer	5.94e-05	0.000478	CcSEcCtD
Lubiprostone—Shock—Capecitabine—prostate cancer	5.94e-05	0.000477	CcSEcCtD
Lubiprostone—Abdominal pain—Etoposide—prostate cancer	5.93e-05	0.000477	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—prostate cancer	5.93e-05	0.000477	CcSEcCtD
Lubiprostone—Nervous system disorder—Capecitabine—prostate cancer	5.92e-05	0.000476	CcSEcCtD
Lubiprostone—Syncope—Prednisone—prostate cancer	5.91e-05	0.000475	CcSEcCtD
Lubiprostone—Tachycardia—Capecitabine—prostate cancer	5.89e-05	0.000474	CcSEcCtD
Lubiprostone—Skin disorder—Capecitabine—prostate cancer	5.87e-05	0.000471	CcSEcCtD
Lubiprostone—Hyperhidrosis—Capecitabine—prostate cancer	5.84e-05	0.000469	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HPGDS—prostate cancer	5.84e-05	0.00114	CbGpPWpGaD
Lubiprostone—Oedema peripheral—Epirubicin—prostate cancer	5.83e-05	0.000469	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—prostate cancer	5.82e-05	0.000468	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2C19—prostate cancer	5.8e-05	0.00113	CbGpPWpGaD
Lubiprostone—Loss of consciousness—Prednisone—prostate cancer	5.79e-05	0.000465	CcSEcCtD
Lubiprostone—Anorexia—Capecitabine—prostate cancer	5.76e-05	0.000462	CcSEcCtD
Lubiprostone—Nausea—Estradiol—prostate cancer	5.75e-05	0.000462	CcSEcCtD
Lubiprostone—Vomiting—Mitoxantrone—prostate cancer	5.74e-05	0.000461	CcSEcCtD
Lubiprostone—Rash—Mitoxantrone—prostate cancer	5.69e-05	0.000457	CcSEcCtD
Lubiprostone—Dermatitis—Mitoxantrone—prostate cancer	5.68e-05	0.000457	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.68e-05	0.000457	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTT1—prostate cancer	5.66e-05	0.0011	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACHE—prostate cancer	5.66e-05	0.0011	CbGpPWpGaD
Lubiprostone—Headache—Mitoxantrone—prostate cancer	5.65e-05	0.000454	CcSEcCtD
Lubiprostone—Myalgia—Prednisone—prostate cancer	5.61e-05	0.000451	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2A6—prostate cancer	5.6e-05	0.00109	CbGpPWpGaD
Lubiprostone—Anxiety—Prednisone—prostate cancer	5.59e-05	0.000449	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.58e-05	0.00108	CbGpPWpGaD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.57e-05	0.000448	CcSEcCtD
Lubiprostone—Dyspnoea—Docetaxel—prostate cancer	5.56e-05	0.000447	CcSEcCtD
Lubiprostone—Discomfort—Prednisone—prostate cancer	5.54e-05	0.000445	CcSEcCtD
Lubiprostone—Hypersensitivity—Etoposide—prostate cancer	5.53e-05	0.000444	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.5e-05	0.000442	CcSEcCtD
Lubiprostone—Dyspepsia—Docetaxel—prostate cancer	5.49e-05	0.000441	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AKR1C3—prostate cancer	5.44e-05	0.00106	CbGpPWpGaD
Lubiprostone—Decreased appetite—Docetaxel—prostate cancer	5.42e-05	0.000436	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PRKACB—prostate cancer	5.42e-05	0.00105	CbGpPWpGaD
Lubiprostone—Oedema peripheral—Doxorubicin—prostate cancer	5.4e-05	0.000434	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Docetaxel—prostate cancer	5.39e-05	0.000433	CcSEcCtD
Lubiprostone—Asthenia—Etoposide—prostate cancer	5.39e-05	0.000433	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—prostate cancer	5.38e-05	0.000433	CcSEcCtD
Lubiprostone—Dyspnoea—Capecitabine—prostate cancer	5.38e-05	0.000433	CcSEcCtD
Lubiprostone—Oedema—Prednisone—prostate cancer	5.38e-05	0.000432	CcSEcCtD
Lubiprostone—Fatigue—Docetaxel—prostate cancer	5.38e-05	0.000432	CcSEcCtD
Lubiprostone—Nausea—Mitoxantrone—prostate cancer	5.36e-05	0.000431	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP17A1—prostate cancer	5.36e-05	0.00104	CbGpPWpGaD
Lubiprostone—Mediastinal disorder—Epirubicin—prostate cancer	5.34e-05	0.000429	CcSEcCtD
Lubiprostone—Constipation—Docetaxel—prostate cancer	5.33e-05	0.000429	CcSEcCtD
Lubiprostone—Pain—Docetaxel—prostate cancer	5.33e-05	0.000429	CcSEcCtD
Lubiprostone—Dyspepsia—Capecitabine—prostate cancer	5.32e-05	0.000427	CcSEcCtD
Lubiprostone—Shock—Prednisone—prostate cancer	5.29e-05	0.000425	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.29e-05	0.00103	CbGpPWpGaD
Lubiprostone—Nervous system disorder—Prednisone—prostate cancer	5.28e-05	0.000424	CcSEcCtD
Lubiprostone—Tachycardia—Prednisone—prostate cancer	5.25e-05	0.000422	CcSEcCtD
Lubiprostone—Decreased appetite—Capecitabine—prostate cancer	5.25e-05	0.000422	CcSEcCtD
Lubiprostone—Skin disorder—Prednisone—prostate cancer	5.23e-05	0.00042	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Capecitabine—prostate cancer	5.21e-05	0.000419	CcSEcCtD
Lubiprostone—Fatigue—Capecitabine—prostate cancer	5.21e-05	0.000418	CcSEcCtD
Lubiprostone—Hyperhidrosis—Prednisone—prostate cancer	5.2e-05	0.000418	CcSEcCtD
Lubiprostone—Mental disorder—Epirubicin—prostate cancer	5.19e-05	0.000417	CcSEcCtD
Lubiprostone—Constipation—Capecitabine—prostate cancer	5.16e-05	0.000415	CcSEcCtD
Lubiprostone—Pain—Capecitabine—prostate cancer	5.16e-05	0.000415	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—prostate cancer	5.16e-05	0.000414	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—prostate cancer	5.16e-05	0.000414	CcSEcCtD
Lubiprostone—Feeling abnormal—Docetaxel—prostate cancer	5.14e-05	0.000413	CcSEcCtD
Lubiprostone—Diarrhoea—Etoposide—prostate cancer	5.14e-05	0.000413	CcSEcCtD
Lubiprostone—Anorexia—Prednisone—prostate cancer	5.13e-05	0.000412	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NCOA2—prostate cancer	5.11e-05	0.000993	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Docetaxel—prostate cancer	5.1e-05	0.00041	CcSEcCtD
Lubiprostone—Flatulence—Epirubicin—prostate cancer	5.08e-05	0.000408	CcSEcCtD
Lubiprostone—Dysgeusia—Epirubicin—prostate cancer	5.05e-05	0.000406	CcSEcCtD
Lubiprostone—Feeling abnormal—Capecitabine—prostate cancer	4.98e-05	0.0004	CcSEcCtD
Lubiprostone—Dizziness—Etoposide—prostate cancer	4.96e-05	0.000399	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—prostate cancer	4.96e-05	0.000398	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Capecitabine—prostate cancer	4.94e-05	0.000397	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—prostate cancer	4.94e-05	0.000397	CcSEcCtD
Lubiprostone—Abdominal pain—Docetaxel—prostate cancer	4.93e-05	0.000396	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Prednisone—prostate cancer	4.9e-05	0.000394	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC5A5—prostate cancer	4.87e-05	0.000948	CbGpPWpGaD
Lubiprostone—Mental disorder—Doxorubicin—prostate cancer	4.8e-05	0.000386	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—prostate cancer	4.78e-05	0.000384	CcSEcCtD
Lubiprostone—Abdominal pain—Capecitabine—prostate cancer	4.77e-05	0.000384	CcSEcCtD
Lubiprostone—Vomiting—Etoposide—prostate cancer	4.77e-05	0.000383	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—prostate cancer	4.77e-05	0.000383	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—prostate cancer	4.77e-05	0.000383	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2E1—prostate cancer	4.76e-05	0.000926	CbGpPWpGaD
Lubiprostone—Dyspepsia—Prednisone—prostate cancer	4.74e-05	0.00038	CcSEcCtD
Lubiprostone—Rash—Etoposide—prostate cancer	4.73e-05	0.00038	CcSEcCtD
Lubiprostone—Dermatitis—Etoposide—prostate cancer	4.73e-05	0.00038	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NQO1—prostate cancer	4.71e-05	0.000915	CbGpPWpGaD
Lubiprostone—Headache—Etoposide—prostate cancer	4.7e-05	0.000378	CcSEcCtD
Lubiprostone—Flatulence—Doxorubicin—prostate cancer	4.7e-05	0.000378	CcSEcCtD
Lubiprostone—Decreased appetite—Prednisone—prostate cancer	4.68e-05	0.000376	CcSEcCtD
Lubiprostone—Dysgeusia—Doxorubicin—prostate cancer	4.67e-05	0.000375	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—prostate cancer	4.65e-05	0.000373	CcSEcCtD
Lubiprostone—Fatigue—Prednisone—prostate cancer	4.64e-05	0.000373	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TH—prostate cancer	4.64e-05	0.000902	CbGpPWpGaD
Lubiprostone—Syncope—Epirubicin—prostate cancer	4.62e-05	0.000371	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.61e-05	0.000896	CbGpPWpGaD
Lubiprostone—Constipation—Prednisone—prostate cancer	4.6e-05	0.00037	CcSEcCtD
Lubiprostone—Hypersensitivity—Docetaxel—prostate cancer	4.6e-05	0.000369	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP3A4—prostate cancer	4.59e-05	0.000893	CbGpPWpGaD
Lubiprostone—Muscle spasms—Doxorubicin—prostate cancer	4.59e-05	0.000368	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.57e-05	0.000888	CbGpPWpGaD
Lubiprostone—Palpitations—Epirubicin—prostate cancer	4.56e-05	0.000366	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—prostate cancer	4.53e-05	0.000364	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP1B1—prostate cancer	4.51e-05	0.000878	CbGpPWpGaD
Lubiprostone—Cough—Epirubicin—prostate cancer	4.5e-05	0.000361	CcSEcCtD
Lubiprostone—Asthenia—Docetaxel—prostate cancer	4.48e-05	0.00036	CcSEcCtD
Lubiprostone—Nausea—Etoposide—prostate cancer	4.46e-05	0.000358	CcSEcCtD
Lubiprostone—Hypersensitivity—Capecitabine—prostate cancer	4.45e-05	0.000357	CcSEcCtD
Lubiprostone—Feeling abnormal—Prednisone—prostate cancer	4.43e-05	0.000356	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—prostate cancer	4.43e-05	0.000356	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Prednisone—prostate cancer	4.4e-05	0.000353	CcSEcCtD
Lubiprostone—Myalgia—Epirubicin—prostate cancer	4.39e-05	0.000353	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—prostate cancer	4.39e-05	0.000353	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—prostate cancer	4.37e-05	0.000351	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GGT1—prostate cancer	4.37e-05	0.00085	CbGpPWpGaD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.36e-05	0.00035	CcSEcCtD
Lubiprostone—Discomfort—Epirubicin—prostate cancer	4.34e-05	0.000348	CcSEcCtD
Lubiprostone—Asthenia—Capecitabine—prostate cancer	4.33e-05	0.000348	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NCOA1—prostate cancer	4.3e-05	0.000837	CbGpPWpGaD
Lubiprostone—Malaise—Doxorubicin—prostate cancer	4.3e-05	0.000346	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—prostate cancer	4.29e-05	0.000345	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—prostate cancer	4.28e-05	0.000344	CcSEcCtD
Lubiprostone—Diarrhoea—Docetaxel—prostate cancer	4.27e-05	0.000343	CcSEcCtD
Lubiprostone—Abdominal pain—Prednisone—prostate cancer	4.25e-05	0.000342	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP19A1—prostate cancer	4.24e-05	0.000825	CbGpPWpGaD
Lubiprostone—Palpitations—Doxorubicin—prostate cancer	4.22e-05	0.000339	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—prostate cancer	4.21e-05	0.000338	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—prostate cancer	4.19e-05	0.000337	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—prostate cancer	4.16e-05	0.000334	CcSEcCtD
Lubiprostone—Shock—Epirubicin—prostate cancer	4.14e-05	0.000333	CcSEcCtD
Lubiprostone—Diarrhoea—Capecitabine—prostate cancer	4.13e-05	0.000332	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—prostate cancer	4.13e-05	0.000331	CcSEcCtD
Lubiprostone—Dizziness—Docetaxel—prostate cancer	4.13e-05	0.000331	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—prostate cancer	4.11e-05	0.00033	CcSEcCtD
Lubiprostone—CBR1—Metabolism—RXRA—prostate cancer	4.09e-05	0.000796	CbGpPWpGaD
Lubiprostone—Skin disorder—Epirubicin—prostate cancer	4.09e-05	0.000328	CcSEcCtD
Lubiprostone—Hyperhidrosis—Epirubicin—prostate cancer	4.07e-05	0.000327	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—prostate cancer	4.06e-05	0.000326	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—prostate cancer	4.06e-05	0.000326	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—prostate cancer	4.05e-05	0.000325	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.03e-05	0.000324	CcSEcCtD
Lubiprostone—Discomfort—Doxorubicin—prostate cancer	4.01e-05	0.000322	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—prostate cancer	4.01e-05	0.000322	CcSEcCtD
Lubiprostone—Dizziness—Capecitabine—prostate cancer	3.99e-05	0.000321	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.98e-05	0.000775	CbGpPWpGaD
Lubiprostone—Dry mouth—Doxorubicin—prostate cancer	3.97e-05	0.000319	CcSEcCtD
Lubiprostone—Vomiting—Docetaxel—prostate cancer	3.97e-05	0.000319	CcSEcCtD
Lubiprostone—Hypersensitivity—Prednisone—prostate cancer	3.96e-05	0.000318	CcSEcCtD
Lubiprostone—CBR1—Metabolism—COMT—prostate cancer	3.94e-05	0.000767	CbGpPWpGaD
Lubiprostone—Rash—Docetaxel—prostate cancer	3.93e-05	0.000316	CcSEcCtD
Lubiprostone—Dermatitis—Docetaxel—prostate cancer	3.93e-05	0.000316	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTP1—prostate cancer	3.92e-05	0.000763	CbGpPWpGaD
Lubiprostone—Headache—Docetaxel—prostate cancer	3.91e-05	0.000314	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—prostate cancer	3.89e-05	0.000313	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ITPR1—prostate cancer	3.86e-05	0.000751	CbGpPWpGaD
Lubiprostone—Asthenia—Prednisone—prostate cancer	3.86e-05	0.00031	CcSEcCtD
Lubiprostone—Vomiting—Capecitabine—prostate cancer	3.84e-05	0.000308	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.83e-05	0.000308	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—prostate cancer	3.83e-05	0.000308	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—prostate cancer	3.82e-05	0.000307	CcSEcCtD
Lubiprostone—Rash—Capecitabine—prostate cancer	3.81e-05	0.000306	CcSEcCtD
Lubiprostone—Dermatitis—Capecitabine—prostate cancer	3.8e-05	0.000306	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—prostate cancer	3.8e-05	0.000305	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.8e-05	0.000739	CbGpPWpGaD
Lubiprostone—Headache—Capecitabine—prostate cancer	3.78e-05	0.000304	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—prostate cancer	3.78e-05	0.000304	CcSEcCtD
Lubiprostone—Hyperhidrosis—Doxorubicin—prostate cancer	3.76e-05	0.000302	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—prostate cancer	3.75e-05	0.000301	CcSEcCtD
Lubiprostone—Anorexia—Doxorubicin—prostate cancer	3.71e-05	0.000298	CcSEcCtD
Lubiprostone—Nausea—Docetaxel—prostate cancer	3.71e-05	0.000298	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—prostate cancer	3.7e-05	0.000298	CcSEcCtD
Lubiprostone—Diarrhoea—Prednisone—prostate cancer	3.68e-05	0.000296	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—prostate cancer	3.66e-05	0.000294	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TYMS—prostate cancer	3.65e-05	0.00071	CbGpPWpGaD
Lubiprostone—Gastrointestinal disorder—Epirubicin—prostate cancer	3.63e-05	0.000292	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—prostate cancer	3.63e-05	0.000291	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTM1—prostate cancer	3.61e-05	0.000702	CbGpPWpGaD
Lubiprostone—Pain—Epirubicin—prostate cancer	3.6e-05	0.000289	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—prostate cancer	3.6e-05	0.000289	CcSEcCtD
Lubiprostone—Nausea—Capecitabine—prostate cancer	3.59e-05	0.000288	CcSEcCtD
Lubiprostone—Dizziness—Prednisone—prostate cancer	3.56e-05	0.000286	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.55e-05	0.000285	CcSEcCtD
Lubiprostone—CBR1—Metabolism—LPL—prostate cancer	3.54e-05	0.000689	CbGpPWpGaD
Lubiprostone—Dyspnoea—Doxorubicin—prostate cancer	3.47e-05	0.000279	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—prostate cancer	3.47e-05	0.000279	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Epirubicin—prostate cancer	3.44e-05	0.000276	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—prostate cancer	3.43e-05	0.000275	CcSEcCtD
Lubiprostone—Vomiting—Prednisone—prostate cancer	3.42e-05	0.000275	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP1A1—prostate cancer	3.42e-05	0.000665	CbGpPWpGaD
Lubiprostone—Rash—Prednisone—prostate cancer	3.39e-05	0.000272	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ERCC2—prostate cancer	3.39e-05	0.00066	CbGpPWpGaD
Lubiprostone—Dermatitis—Prednisone—prostate cancer	3.39e-05	0.000272	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—prostate cancer	3.38e-05	0.000272	CcSEcCtD
Lubiprostone—Headache—Prednisone—prostate cancer	3.37e-05	0.000271	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.36e-05	0.00027	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—prostate cancer	3.36e-05	0.00027	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—prostate cancer	3.33e-05	0.000267	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—prostate cancer	3.33e-05	0.000267	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—prostate cancer	3.33e-05	0.000267	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—prostate cancer	3.21e-05	0.000258	CcSEcCtD
Lubiprostone—Nausea—Prednisone—prostate cancer	3.2e-05	0.000257	CcSEcCtD
Lubiprostone—CBR1—Metabolism—MTHFR—prostate cancer	3.19e-05	0.00062	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Doxorubicin—prostate cancer	3.18e-05	0.000256	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PPARA—prostate cancer	3.13e-05	0.000608	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Epirubicin—prostate cancer	3.1e-05	0.000249	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—prostate cancer	3.08e-05	0.000247	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—prostate cancer	3.02e-05	0.000243	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CAV1—prostate cancer	2.94e-05	0.000572	CbGpPWpGaD
Lubiprostone—Diarrhoea—Epirubicin—prostate cancer	2.88e-05	0.000231	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—prostate cancer	2.87e-05	0.00023	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.81e-05	0.000546	CbGpPWpGaD
Lubiprostone—Asthenia—Doxorubicin—prostate cancer	2.79e-05	0.000224	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—prostate cancer	2.78e-05	0.000224	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PIK3CG—prostate cancer	2.68e-05	0.000521	CbGpPWpGaD
Lubiprostone—Vomiting—Epirubicin—prostate cancer	2.68e-05	0.000215	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—prostate cancer	2.66e-05	0.000214	CcSEcCtD
Lubiprostone—Rash—Epirubicin—prostate cancer	2.65e-05	0.000213	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—prostate cancer	2.65e-05	0.000213	CcSEcCtD
Lubiprostone—Headache—Epirubicin—prostate cancer	2.64e-05	0.000212	CcSEcCtD
Lubiprostone—Dizziness—Doxorubicin—prostate cancer	2.57e-05	0.000207	CcSEcCtD
Lubiprostone—CBR1—Metabolism—INS—prostate cancer	2.53e-05	0.000493	CbGpPWpGaD
Lubiprostone—Nausea—Epirubicin—prostate cancer	2.5e-05	0.000201	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CREBBP—prostate cancer	2.48e-05	0.000483	CbGpPWpGaD
Lubiprostone—Vomiting—Doxorubicin—prostate cancer	2.48e-05	0.000199	CcSEcCtD
Lubiprostone—Rash—Doxorubicin—prostate cancer	2.45e-05	0.000197	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—prostate cancer	2.45e-05	0.000197	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—prostate cancer	2.44e-05	0.000196	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PIK3CD—prostate cancer	2.35e-05	0.000458	CbGpPWpGaD
Lubiprostone—Nausea—Doxorubicin—prostate cancer	2.31e-05	0.000186	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NOS3—prostate cancer	2.22e-05	0.000432	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CB—prostate cancer	2.05e-05	0.000399	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—prostate cancer	2.03e-05	0.000396	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTEN—prostate cancer	1.77e-05	0.000345	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—EP300—prostate cancer	1.69e-05	0.000329	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CA—prostate cancer	1.25e-05	0.000243	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—prostate cancer	1.02e-05	0.000199	CbGpPWpGaD
